Literature DB >> 23814808

[Laryngeal papillomatosis: problem update].

V M Svistushkin, D M Mustafaev.   

Abstract

The objective of the present overview was to analyse the available data on etiology, pathogenesis, diagnostics, and treatment of laryngeal papillomatosis. It is shown that the pathogenetic mechanism underlying the development of this pathology is related to cell proliferation mechanisms. The human papilloma virus is most effectively identified by the polymerase chain reaction technique in combination with in situ hybridization. It is expected that new and more informative criteria for diagnostics, treatment,and prognosis of laryngeal papillomatosis will be proposed based on recent progress in molecular biology, morphology,and immunology. Different variants of the therapeutic strategy for the treatment of laryngeal papillomatosis are described.Modern practice of the management of laryngeal papillomatosis takes advantage of the three main approaches and/or their combination. First, further improvement of surgical techniques, such as the application of endoscopic devices and surgical lasers.Second, the search for new pharmaceutical agents (indole-3-carbinol, cidofovir, antiviral medicines, etc.) most frequently used for adjuvant therapy. Third, the development of new vaccination methods. Besides these three approaches, photodynamic therapy and the use of ionizing radiation are currently being studied as the tools for the treatment of extensive and recurrent laryngeal papillomatosis as well as the methods of laser-induced interstitial thermotherapy.

Entities:  

Mesh:

Year:  2013        PMID: 23814808

Source DB:  PubMed          Journal:  Vestn Otorinolaringol        ISSN: 0042-4668


  1 in total

1.  Dysphonia as a sign of HPV laryngeal infection: a case report.

Authors:  Carlos Eduardo Gama Longubuco; Helena Lucia Barroso dos Reis; Fernanda Sampaio Cavalcante; Carla Renata Petillo de Pinho; Nathalia Silva Oliveira; Alcina Frederica Nicol; Renata Quintella Zamolyi; Dennis de Carvalho Ferreira
Journal:  BMC Res Notes       Date:  2014-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.